$AMRK
A-Mark Precious Metals, Inc. Stock $amrk

$amrk Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000095017023047575 Filed on September 12, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$2.485B	$3.155B	$9.322B
YoY Change	30.75%	50.98%	14.26%
Cost Of Revenue	$2.435B	$3.077B	$9.028B
YoY Change	33.53%	52.15%	14.31%
Gross Profit	$49.41M	$78.61M	$294.7M
YoY Change	-35.5%	16.03%	12.57%
Gross Profit Margin	1.99%	2.49%	3.16%
Selling, General & Admin	$21.85M	$22.84M	$85.28M
YoY Change	22.84%	10.18%	11.31%
% of Gross Profit	44.22%	29.06%	28.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.792M	$2.741M	$12.53M
YoY Change	-12.31%	-14.96%	-54.12%
% of Gross Profit	5.65%	3.49%	4.25%
Operating Expenses	$21.85M	$24.92M	$95.14M
YoY Change	22.84%	6.79%	-6.69%
Operating Profit	$27.56M	$53.69M	$199.5M
YoY Change	-53.14%	20.89%	24.86%
Interest Expense	$9.823M	$2.555M	$3.645M
YoY Change	60.24%	-1.73%	-44.91%
% of Operating Profit	35.64%	4.76%	1.83%
Other Income/Expense, Net	$273.0K		$2.663M
YoY Change	-48.2%		36.35%
Pretax Income	$23.94M	$56.24M	$203.2M
YoY Change	-58.74%	19.64%	22.08%
Income Tax	$4.952M	$14.31M	$46.40M
% Of Pretax Income	20.69%	25.43%	22.84%
Net Earnings	$18.83M	$41.83M	$156.4M
YoY Change	-58.28%	12.05%	17.98%
Net Earnings / Revenue	0.76%	1.33%	1.68%
Basic Earnings Per Share	$0.81		$6.68
Diluted Earnings Per Share	$0.77	$1.71	$6.34
COMMON SHARES
Basic Shares Outstanding	23.34M	23.26M	23.40M
Diluted Shares Outstanding	24.53M		24.65M

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$48.20M	$39.32M	$39.32M
YoY Change	-25.43%	4.06%	4.06%
Cash & Equivalents	$48.25M	$39.32M
Short-Term Investments
Other Short-Term Assets	$112.4M	$110.4M	$110.4M
YoY Change	23.56%	-38.37%	-38.37%
Inventory	$611.2M	$981.6M	$981.6M
Prepaid Expenses
Receivables	$34.32M	$35.24M	$35.24M
Other Receivables	$100.1M	$100.6M	$100.6M
Total Short-Term Assets	$1.295B	$1.267B	$1.267B
YoY Change	32.23%	7.29%	7.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.69M	$17.63M	$17.63M
YoY Change	30.7%	7.99%	7.99%
Goodwill	$100.9M	$100.9M
YoY Change	0.0%	0.0%
Intangibles	$60.47M	$62.63M
YoY Change	-7.34%	-7.85%
Long-Term Investments	$91.00M	$88.54M	$88.54M
YoY Change	25.0%	25.0%	25.0%
Other Assets	$13.17M	$8.640M	$8.640M
YoY Change	140.72%	57.92%	57.92%
Total Long-Term Assets	$284.3M	$278.4M	$278.4M
YoY Change	8.87%	6.44%	6.44%
TOTAL ASSETS
Total Short-Term Assets	$1.295B	$1.267B	$1.267B
Total Long-Term Assets	$284.3M	$278.4M	$278.4M
Total Assets	$1.579B	$1.546B	$1.546B
YoY Change	27.32%	7.13%	7.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.800M	$25.47M	$25.47M
YoY Change	-69.2%	315.62%	315.62%
Accrued Expenses	$14.56M	$20.42M	$20.42M
YoY Change	-17.55%	-6.4%	-6.4%
Deferred Revenue
YoY Change
Short-Term Debt	$411.3M	$592.5M	$592.5M
YoY Change	43.85%	6.35%	6.35%
Long-Term Debt Due	$95.20M	$95.31M	$95.31M
YoY Change
Total Short-Term Liabilities	$705.0M	$924.1M	$924.1M
YoY Change	14.54%	10.44%	10.44%
LONG-TERM LIABILITIES
Long-Term Debt	$270.0M	$0.00	$0.00
YoY Change	175.0%	-100.0%	-100.0%
Other Long-Term Liabilities	$4.439M	$4.440M	$4.440M
YoY Change	-19.04%	-25.65%	-25.65%
Total Long-Term Liabilities	$4.439M	$4.440M	$4.440M
YoY Change	-19.04%	-95.56%	-95.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$705.0M	$924.1M	$924.1M
Total Long-Term Liabilities	$4.439M	$4.440M	$4.440M
Total Liabilities	$996.2M	$946.4M	$946.4M
YoY Change	35.62%	-0.8%	-0.8%
SHAREHOLDERS EQUITY
Retained Earnings	$426.7M	$440.6M
YoY Change	25.93%	36.91%
Common Stock	$170.6M	$169.3M
YoY Change	2.74%	1.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$14.80M	$9.762M
YoY Change
Treasury Stock Shares		$335.7K
Shareholders Equity	$581.7M	$599.1M	$599.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.579B	$1.546B	$1.546B
YoY Change	27.32%	7.13%	7.13%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	$18.83M	$41.83M	$156.4M
YoY Change	-58.28%	12.05%	17.98%
Depreciation, Depletion And Amortization	$2.792M	$2.741M	$12.53M
YoY Change	-12.31%	-14.96%	-54.12%
Cash From Operating Activities	-$44.26M	-$73.57M	-$30.32M
YoY Change	-115.83%	446.43%	-65.99%
INVESTING ACTIVITIES
Capital Expenditures	$1.886M	$2.056M	$9.783M
YoY Change	103.45%	-365.98%	-439.81%
Acquisitions			$0.00
YoY Change
Other Investing Activities	$1.500M	-$6.197M	$16.62M
YoY Change	-96.06%	-67.5%	-128.82%
Cash From Investing Activities	-$428.0K	-$8.253M	$6.839M
YoY Change	-101.15%	-58.41%	-111.29%
FINANCING ACTIVITIES
Cash Dividend Paid	$28.03M		$37.47M
YoY Change	19.83%		65.46%
Common Stock Issuance & Retirement, Net			-$7.878M
YoY Change			-444.32%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	53.62M	43.04M	25.02M
YoY Change	-118.5%	1.18%	-70.94%
NET CHANGE
Cash From Operating Activities	-44.26M	-73.57M	-30.32M
Cash From Investing Activities	-428.0K	-8.253M	6.839M
Cash From Financing Activities	53.62M	43.04M	25.02M
Net Change In Cash	8.927M	-38.78M	1.535M
YoY Change	-66.75%	-520.0%	-102.41%
FREE CASH FLOW
Cash From Operating Activities	-$44.26M	-$73.57M	-$30.32M
Capital Expenditures	$1.886M	$2.056M	$9.783M
Free Cash Flow	-$46.15M	-$75.63M	-$40.11M
YoY Change	-116.56%	495.92%	-53.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001591588
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Registrant Name EntityRegistrantName	A-Mark Precious Metals, Inc.
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.amark.com/20230630#AccountsPayableAndOtherPayables
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-36347
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-2464169
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2121 Rosecrans Ave
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 6300
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	El Segundo
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90245
CY2023	dei	City Area Code CityAreaCode	310
CY2023	dei	Local Phone Number LocalPhoneNumber	587-1477
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	AMRK
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	622270086000
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23344221
CY2023	dei	Auditor Firm AuditorFirmId	248
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2023	dei	Auditor Location AuditorLocation	Newport Beach, California
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39318000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37783000
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35243000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	97040000
CY2023Q2	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	77881000
CY2022Q2	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	91743000
CY2023Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	100620000
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	126217000
CY2023Q2	amrk	Asset Under Financing Agreement With Repurchase Option AssetUnderFinancingAgreementWithRepurchaseOption	25530000
CY2022Q2	amrk	Asset Under Financing Agreement With Repurchase Option AssetUnderFinancingAgreementWithRepurchaseOption	79766000
CY2023Q2	us-gaap	Inventory Net InventoryNet	645812000
CY2022Q2	us-gaap	Inventory Net InventoryNet	458347000
CY2023Q2	amrk	Restricted Inventory RestrictedInventory	335831000
CY2022Q2	amrk	Restricted Inventory RestrictedInventory	282671000
CY2023Q2	amrk	Restricted And Non Restricted Inventory Net RestrictedAndNonRestrictedInventoryNet	981643000
CY2022Q2	amrk	Restricted And Non Restricted Inventory Net RestrictedAndNonRestrictedInventoryNet	741018000
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6956000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7558000
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1267191000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1181125000
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5119000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6482000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12513000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9845000
CY2023Q2	us-gaap	Goodwill Goodwill	100943000
CY2022Q2	us-gaap	Goodwill Goodwill	100943000
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	62630000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	67965000
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	88535000
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	70828000
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8640000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5471000
CY2023Q2	us-gaap	Assets Assets	1545571000
CY2022Q2	us-gaap	Assets Assets	1442659000
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	235000000
CY2022Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	215000000
CY2023Q2	amrk	Liability On Borrowed Metals LiabilityOnBorrowedMetals	21642000
CY2022Q2	amrk	Liability On Borrowed Metals LiabilityOnBorrowedMetals	59417000
CY2023Q2	amrk	Obligation Under Product Financing Agreement ObligationUnderProductFinancingAgreement	335831000
CY2022Q2	amrk	Obligation Under Product Financing Agreement ObligationUnderProductFinancingAgreement	282671000
CY2023Q2	amrk	Accounts Payable And Other Payables AccountsPayableAndOtherPayables	25465000
CY2022Q2	amrk	Accounts Payable And Other Payables AccountsPayableAndOtherPayables	6127000
CY2023Q2	amrk	Deferred Revenue And Other Advances Current DeferredRevenueAndOtherAdvancesCurrent	181363000
CY2022Q2	amrk	Deferred Revenue And Other Advances Current DeferredRevenueAndOtherAdvancesCurrent	175545000
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	8076000
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	75780000
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20418000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21813000
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	958000
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	382000
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	95308000
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	0
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	924061000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	836735000
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	0
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	94073000
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	16677000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	15408000
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4440000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5972000
CY2023Q2	us-gaap	Liabilities Liabilities	945178000
CY2022Q2	us-gaap	Liabilities Liabilities	952188000
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23672122
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23379888
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23336387
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23379888
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	237000
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	234000
CY2023Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	335735
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	0
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	9762000
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	169034000
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	166526000
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1025000
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	440639000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	321849000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	599123000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	488609000
CY2023Q2	us-gaap	Minority Interest MinorityInterest	1270000
CY2022Q2	us-gaap	Minority Interest MinorityInterest	1862000
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	600393000
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	490471000
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1545571000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1442659000
CY2023	us-gaap	Revenues Revenues	9286561000
CY2022	us-gaap	Revenues Revenues	8159254000
CY2021	us-gaap	Revenues Revenues	7613015000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8991892000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7897489000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7402817000
CY2023	us-gaap	Gross Profit GrossProfit	294669000
CY2022	us-gaap	Gross Profit GrossProfit	261765000
CY2021	us-gaap	Gross Profit GrossProfit	210198000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	85282000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	76618000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48020000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12525000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	27300000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10789000
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	22231000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	21800000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	18474000
CY2023	us-gaap	Interest Expense InterestExpense	31528000
CY2022	us-gaap	Interest Expense InterestExpense	21992000
CY2021	us-gaap	Interest Expense InterestExpense	19865000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12576000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6907000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15547000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2663000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1953000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1079000
CY2021	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	26306000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	366000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-98000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-129000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	203170000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	166417000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	192801000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46401000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33338000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31877000
CY2023	us-gaap	Profit Loss ProfitLoss	156769000
CY2022	us-gaap	Profit Loss ProfitLoss	133079000
CY2021	us-gaap	Profit Loss ProfitLoss	160924000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	409000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	543000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1287000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	156360000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	132536000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	159637000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.68
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.81
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.57
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.34
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.45
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	8.90
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23400300
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22805600
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16686600
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24648600
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24329500
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17944600
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	104894000
CY2021	us-gaap	Profit Loss ProfitLoss	160924000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1173000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	75344000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	41608000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3523000
CY2021	amrk	Stock Issued During Period Value Settlement Of Share Based Awards Net StockIssuedDuringPeriodValueSettlementOfShareBasedAwardsNet	-38000
CY2021	amrk	Adjustments To Additional Paid In Capital Acquisition Of Noncontrolling Interest Net Of Deferred Taxes AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterestNetOfDeferredTaxes	-2295000
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	21191000
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	363942000
CY2022	us-gaap	Profit Loss ProfitLoss	133079000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2140000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2323000
CY2022	amrk	Stock Issued During Period Value Settlement Of Share Based Awards Net StockIssuedDuringPeriodValueSettlementOfShareBasedAwardsNet	-35000
CY2022	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	11683000
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	22661000
CY2022	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	490471000
CY2023	us-gaap	Profit Loss ProfitLoss	156769000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2176000
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1001000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1025000
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	293000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1884000
CY2023	amrk	Stock Issued During Period Value Settlement Of Share Based Awards Net StockIssuedDuringPeriodValueSettlementOfShareBasedAwardsNet	-1854000
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	9762000
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	600393000
CY2023	us-gaap	Profit Loss ProfitLoss	156769000
CY2022	us-gaap	Profit Loss ProfitLoss	133079000
CY2021	us-gaap	Profit Loss ProfitLoss	160924000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12525000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	27300000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10789000
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2113000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2651000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2162000
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1585000
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	4106000
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	2034000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2176000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2140000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1173000
CY2023	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0
CY2022	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0
CY2021	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	26306000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12576000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6907000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15547000
CY2023	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	978000
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1678000
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	343000
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-155000
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	215000
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-13000
CY2023	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-61797000
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	8040000
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	20880000
CY2023	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	-1012000
CY2022	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	-757000
CY2021	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	-1932000
CY2023	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	0
CY2022	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-3042000
CY2021	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-5755000
CY2023	us-gaap	Increase Decrease In Derivative Assets IncreaseDecreaseInDerivativeAssets	-13862000
CY2022	us-gaap	Increase Decrease In Derivative Assets IncreaseDecreaseInDerivativeAssets	47207000
CY2021	us-gaap	Increase Decrease In Derivative Assets IncreaseDecreaseInDerivativeAssets	-7447000
CY2023	amrk	Increase Decrease In Assets Held Under Financing Arrangements With Repurchase Option IncreaseDecreaseInAssetsHeldUnderFinancingArrangementsWithRepurchaseOption	-54236000
CY2022	amrk	Increase Decrease In Assets Held Under Financing Arrangements With Repurchase Option IncreaseDecreaseInAssetsHeldUnderFinancingArrangementsWithRepurchaseOption	-74976000
CY2021	amrk	Increase Decrease In Assets Held Under Financing Arrangements With Repurchase Option IncreaseDecreaseInAssetsHeldUnderFinancingArrangementsWithRepurchaseOption	-23835000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	240625000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	282999000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	79031000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3336000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	649000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7000
CY2023	amrk	Increase Decrease In Accounts Payable And Other Payables IncreaseDecreaseInAccountsPayableAndOtherPayables	19338000
CY2022	amrk	Increase Decrease In Accounts Payable And Other Payables IncreaseDecreaseInAccountsPayableAndOtherPayables	192000
CY2021	amrk	Increase Decrease In Accounts Payable And Other Payables IncreaseDecreaseInAccountsPayableAndOtherPayables	-86097000
CY2023	amrk	Increase Decrease In Deferred Revenue And Other Advances IncreaseDecreaseInDeferredRevenueAndOtherAdvances	5818000
CY2022	amrk	Increase Decrease In Deferred Revenue And Other Advances IncreaseDecreaseInDeferredRevenueAndOtherAdvances	-18871000
CY2021	amrk	Increase Decrease In Deferred Revenue And Other Advances IncreaseDecreaseInDeferredRevenueAndOtherAdvances	58651000
CY2023	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-67704000
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	68241000
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-20194000
CY2023	us-gaap	Increase Decrease In Securities Borrowed IncreaseDecreaseInSecuritiesBorrowed	37775000
CY2022	us-gaap	Increase Decrease In Securities Borrowed IncreaseDecreaseInSecuritiesBorrowed	32449000
CY2021	us-gaap	Increase Decrease In Securities Borrowed IncreaseDecreaseInSecuritiesBorrowed	76340000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-937000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2425000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5686000
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	576000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-4634000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-4902000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-30323000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-89166000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-52654000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4783000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2879000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2113000
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	7950000
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	34950000
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	7996000
CY2023	amrk	Payment For Purchase Of An Option To Acquire Long Term Investments PaymentForPurchaseOfAnOptionToAcquireLongTermInvestments	340000
CY2022	amrk	Payment For Purchase Of An Option To Acquire Long Term Investments PaymentForPurchaseOfAnOptionToAcquireLongTermInvestments	5300000
CY2021	amrk	Payment For Purchase Of An Option To Acquire Long Term Investments PaymentForPurchaseOfAnOptionToAcquireLongTermInvestments	0
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5000000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0
CY2023	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-24599000
CY2022	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	17034000
CY2021	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	56932000
CY2023	amrk	Acquisition Of Remaining Noncontrolling Equity Interest In Joint Venture AcquisitionOfRemainingNoncontrollingEquityInterestInJointVenture	0
CY2022	amrk	Acquisition Of Remaining Noncontrolling Equity Interest In Joint Venture AcquisitionOfRemainingNoncontrollingEquityInterestInJointVenture	0
CY2021	amrk	Acquisition Of Remaining Noncontrolling Equity Interest In Joint Venture AcquisitionOfRemainingNoncontrollingEquityInterestInJointVenture	1950000
CY2023	amrk	Purchase Of Digital Assets PurchaseOfDigitalAssets	0
CY2022	amrk	Purchase Of Digital Assets PurchaseOfDigitalAssets	400000
CY2021	amrk	Purchase Of Digital Assets PurchaseOfDigitalAssets	0
CY2023	amrk	Proceeds From The Sales Of Digital Assets ProceedsFromTheSalesOfDigitalAssets	313000
CY2022	amrk	Proceeds From The Sales Of Digital Assets ProceedsFromTheSalesOfDigitalAssets	0
CY2021	amrk	Proceeds From The Sales Of Digital Assets ProceedsFromTheSalesOfDigitalAssets	0
CY2023	amrk	Redemption Associated With Acquisition Of Preexisting Equity Method Investment RedemptionAssociatedWithAcquisitionOfPreexistingEquityMethodInvestment	0
CY2022	amrk	Redemption Associated With Acquisition Of Preexisting Equity Method Investment RedemptionAssociatedWithAcquisitionOfPreexistingEquityMethodInvestment	0
CY2021	amrk	Redemption Associated With Acquisition Of Preexisting Equity Method Investment RedemptionAssociatedWithAcquisitionOfPreexistingEquityMethodInvestment	17457000
CY2023	amrk	Incremental Acquisition Of Pre Existing Equity Method Investment Net Of Cash IncrementalAcquisitionOfPreExistingEquityMethodInvestmentNetOfCash	0
CY2022	amrk	Incremental Acquisition Of Pre Existing Equity Method Investment Net Of Cash IncrementalAcquisitionOfPreExistingEquityMethodInvestmentNetOfCash	0
CY2021	amrk	Incremental Acquisition Of Pre Existing Equity Method Investment Net Of Cash IncrementalAcquisitionOfPreExistingEquityMethodInvestmentNetOfCash	78859000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6839000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-60563000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-130393000
CY2023	amrk	Payments For Product Financing Arrangements Net PaymentsForProductFinancingArrangementsNet	-53160000
CY2022	amrk	Payments For Product Financing Arrangements Net PaymentsForProductFinancingArrangementsNet	-81643000
CY2021	amrk	Payments For Product Financing Arrangements Net PaymentsForProductFinancingArrangementsNet	-126350000
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	37468000
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	22645000
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	21191000
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1001000
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	20000000
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	30000000
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	50000000
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2955000
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9762000
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3500000
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	485000
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5179000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1861000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75344000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1884000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2323000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3523000
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1854000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	35000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	38000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25019000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	86107000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	232127000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1535000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-63622000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49080000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37783000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	101405000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52325000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39318000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37783000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	101405000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	28787000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	20576000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	17933000
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	44337000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	42548000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	42426000
CY2023	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	124000
CY2022	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	122000
CY2021	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	3887000
CY2023	amrk	Non Cash Investing And Financing Declared Distributions And Unpaid Dividends NonCashInvestingAndFinancingDeclaredDistributionsAndUnpaidDividends	90000
CY2022	amrk	Non Cash Investing And Financing Declared Distributions And Unpaid Dividends NonCashInvestingAndFinancingDeclaredDistributionsAndUnpaidDividends	0
CY2021	amrk	Non Cash Investing And Financing Declared Distributions And Unpaid Dividends NonCashInvestingAndFinancingDeclaredDistributionsAndUnpaidDividends	0
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	76000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0
CY2023	amrk	Noncash Investingand Financing Interest Addedto Principal Finance Receivable NoncashInvestingandFinancingInterestAddedtoPrincipalFinanceReceivable	14000
CY2022	amrk	Noncash Investingand Financing Interest Addedto Principal Finance Receivable NoncashInvestingandFinancingInterestAddedtoPrincipalFinanceReceivable	14000
CY2021	amrk	Noncash Investingand Financing Interest Addedto Principal Finance Receivable NoncashInvestingandFinancingInterestAddedtoPrincipalFinanceReceivable	13000
CY2023	amrk	Non Cash Investing And Financing Fair Value Of Shares Exchanged In Acquisitions NonCashInvestingAndFinancingFairValueOfSharesExchangedInAcquisitions	0
CY2022	amrk	Non Cash Investing And Financing Fair Value Of Shares Exchanged In Acquisitions NonCashInvestingAndFinancingFairValueOfSharesExchangedInAcquisitions	11683000
CY2021	amrk	Non Cash Investing And Financing Fair Value Of Shares Exchanged In Acquisitions NonCashInvestingAndFinancingFairValueOfSharesExchangedInAcquisitions	41608000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2013000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3
CY2023	amrk	Number Of Coins And Bar Products NumberOfCoinsAndBarProducts	1800
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. These estimates include, among others, determination of fair value (primarily, with respect to precious metal inventory, derivatives, certain financial instruments, and certain investments), impairment assessments of property, plant and equipment and intangible assets, valuation allowance determination on deferred tax assets, determining the incremental borrowing rate for calculating right of use assets and lease liabilities, and revenue recognition judgments. Actual results could materially differ from these estimates.</span></p>
CY2023Q2	us-gaap	Minority Interest MinorityInterest	1270000
CY2023	amrk	Metals Purchase By Customer Maximum Period MetalsPurchaseByCustomerMaximumPeriod	P1Y
CY2023	amrk	Metal Delivers To Customer After Receiving Customers Deposit Based On Prevailing Current Spot Price Percentage MetalDeliversToCustomerAfterReceivingCustomersDepositBasedOnPrevailingCurrentSpotPricePercentage	1.10
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">Cash is maintained at financial institutions, and, at times, balances may exceed federally insured limits. The Company has not experienced any losses related to these balances.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">Assets that potentially subject the Company to concentrations of credit risk consist principally of receivables, loans of inventory to customers, and inventory hedging transactions. Based on an assessment of credit risk, the Company typically grants collateralized credit to its customers. Credit risk with respect to loans of inventory to customers is minimal. The Company enters into inventory hedging transactions, principally utilizing metals commodity futures contracts traded on national futures exchanges or forward contracts with credit worthy financial institutions. All of our commodity derivative contracts are under master netting arrangements and include both asset and liability positions. Substantially all of these transactions are secured by the underlying metals positions.</span></p>
CY2023	amrk	Unpriced Metal Is Subject To Margin Call If Deposit Falls Below Percentage Of Value Of Unpriced Metal UnpricedMetalIsSubjectToMarginCallIfDepositFallsBelowPercentageOfValueOfUnpricedMetal	1.05
CY2023	amrk	Financing Arrangements Notice Period To Terminate Contract FinancingArrangementsNoticePeriodToTerminateContract	P14D
CY2023Q2	amrk	Asset Under Financing Agreement With Repurchase Option AssetUnderFinancingAgreementWithRepurchaseOption	25500000
CY2022Q2	amrk	Asset Under Financing Agreement With Repurchase Option AssetUnderFinancingAgreementWithRepurchaseOption	79800000
CY2023	amrk	Percentage To Remit Partial Payment Of Order Price PercentageToRemitPartialPaymentOfOrderPrice	0.20
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1258000
CY2020Q2	us-gaap	Minority Interest MinorityInterest	3890000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1287000
CY2021	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	3858000
CY2021Q2	us-gaap	Minority Interest MinorityInterest	1319000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	543000
CY2022Q2	us-gaap	Minority Interest MinorityInterest	1862000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	409000
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1001000
CY2023	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">Interest Income</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">In accordance with </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;font-style:italic;min-width:fit-content;">Interest</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;"> Topic 835 of the ASC ("ASC 835"), the following are interest income generating activities of the Company:</span></p><div style="margin-left:4.537%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">• </span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Times New Roman',serif;font-style:italic;min-width:fit-content;">Secured Loans — </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">The Company uses the effective interest method to recognize interest income on its secured loans transactions. The Company maintains a security interest in the precious metals and records interest income over the terms of the secured loan receivable. Recognition of interest income is suspended, and the loan is placed on non-accrual status when management determines that collection of future interest income is not probable. The interest income accrual is resumed, and previously suspended interest income is recognized, when the loan becomes contractually current and/or collection doubts are resolved. Cash receipts on impaired loans are recorded first against the principal and then to any unrecognized interest income. (See </span><a href="#n5_secured_loans_receivable"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">Note 5</span></a><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">.)</span></div></div><div style="margin-left:4.537%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">• </span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Times New Roman',serif;font-style:italic;min-width:fit-content;">Margin accounts</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;font-style:italic;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Times New Roman',serif;font-style:italic;min-width:fit-content;">— </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">The Company earns a fee (interest income) under financing arrangements related to margin orders over the period during which customers have opted to defer making full payment on the purchase of metals.</span></div></div><div style="margin-left:4.537%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">• </span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Times New Roman',serif;font-style:italic;min-width:fit-content;">Repurchase agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;font-style:italic;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Times New Roman',serif;font-style:italic;min-width:fit-content;">— </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">Repurchase agreements represent a form of secured financing whereby the Company sets aside specific metals for a customer and charges a fee on the outstanding value of these metals. The customer is granted the option (but not the obligation) to repurchase these metals at any time during the open reacquisition period. This fee is earned over the duration of the open reacquisition period and is classified as interest income.</span></div></div><div style="margin-left:4.537%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">• </span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Times New Roman',serif;font-style:italic;min-width:fit-content;">Spot deferred orders</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;font-style:italic;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Times New Roman',serif;font-style:italic;min-width:fit-content;">— </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:'Times New Roman',serif;min-width:fit-content;">Spot deferred orders are a special type of forward delivery order that enable customers to purchase or sell certain precious metals from/to the Company at an agreed upon price but, are allowed to delay remitting or taking delivery up to a maximum of two years from the date of order. Even though the contract allows for physical delivery, it rarely occurs for this type of order. As a result, revenue is not recorded from these transactions. Spot deferred orders are considered a type of financing transaction, where the Company earns a fee (interest income) under spot deferred arrangements over the period in which the order is open.</span></div></div>
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2100000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2700000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2200000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23400000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22806000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16687000
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1249000
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1524000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	15900000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	12200000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	5000000.0
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24649000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24330000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17945000
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	43000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	337000
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23336387
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23379888
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22459314
CY2023Q2	amrk	Inventory Commemorative Coin Stated At Lower Cost Or Market InventoryCommemorativeCoinStatedAtLowerCostOrMarket	900000
CY2022Q2	amrk	Inventory Commemorative Coin Stated At Lower Cost Or Market InventoryCommemorativeCoinStatedAtLowerCostOrMarket	1400000
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35243000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	97040000
CY2023Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	100620000
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	126217000
CY2023	amrk	Loans Receivable Average Effective Rate Of Interest LoansReceivableAverageEffectiveRateOfInterest	0.104
CY2022	amrk	Loans Receivable Average Effective Rate Of Interest LoansReceivableAverageEffectiveRateOfInterest	0.094
CY2023	amrk	Loans Receivable Payment Terms For Interest LoansReceivablePaymentTermsForInterest	P180D
CY2023	amrk	Loan Receivable Liquidation Period Post Default LoanReceivableLiquidationPeriodPostDefault	P20D
CY2023Q2	us-gaap	Notes Receivable Net NotesReceivableNet	100620000
CY2023Q2	amrk	Percentage Of Loans Receivable PercentageOfLoansReceivable	1.000
CY2022Q2	us-gaap	Notes Receivable Net NotesReceivableNet	126217000
CY2022Q2	amrk	Percentage Of Loans Receivable PercentageOfLoansReceivable	1.000
CY2023	amrk	Loan Collateral Values Updated Period Frequency LoanCollateralValuesUpdatedPeriodFrequency	P90D
CY2023Q2	amrk	Restricted And Non Restricted Inventory Net RestrictedAndNonRestrictedInventoryNet	981643000
CY2022Q2	amrk	Restricted And Non Restricted Inventory Net RestrictedAndNonRestrictedInventoryNet	741018000
CY2023Q2	amrk	Inventory Subjectto Repurchase Agreement InventorySubjecttoRepurchaseAgreement	181800000
CY2022Q2	amrk	Inventory Subjectto Repurchase Agreement InventorySubjecttoRepurchaseAgreement	130200000
CY2023Q2	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	3800000
CY2022Q2	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	2500000
CY2023Q2	amrk	Inventory Commemorative Coin Stated At Lower Cost Or Market InventoryCommemorativeCoinStatedAtLowerCostOrMarket	900000
CY2022Q2	amrk	Inventory Commemorative Coin Stated At Lower Cost Or Market InventoryCommemorativeCoinStatedAtLowerCostOrMarket	1400000
CY2023Q2	amrk	Product Under Financing Arrangement ProductUnderFinancingArrangement	335800000
CY2022Q2	amrk	Product Under Financing Arrangement ProductUnderFinancingArrangement	282700000
CY2023	amrk	Inventory Unrealized Gains Losses Resulting From Market Value And Cost Of Physical Inventory InventoryUnrealizedGainsLossesResultingFromMarketValueAndCostOfPhysicalInventory	-4600000
CY2022	amrk	Inventory Unrealized Gains Losses Resulting From Market Value And Cost Of Physical Inventory InventoryUnrealizedGainsLossesResultingFromMarketValueAndCostOfPhysicalInventory	-15400000
CY2023Q2	amrk	Inventory Purchase Premium On Metals Positionmarkedtomarket InventoryPurchasePremiumOnMetalsPositionmarkedtomarket	29400000
CY2022Q2	amrk	Inventory Purchase Premium On Metals Positionmarkedtomarket InventoryPurchasePremiumOnMetalsPositionmarkedtomarket	27100000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1460000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1403000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1509000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	469000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	627000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	426000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	108000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	94000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	91000
CY2022	amrk	Finance Lease Cost FinanceLeaseCost	16000
CY2021	amrk	Finance Lease Cost FinanceLeaseCost	21000
CY2023	us-gaap	Lease Cost LeaseCost	2037000
CY2022	us-gaap	Lease Cost LeaseCost	2140000
CY2021	us-gaap	Lease Cost LeaseCost	2047000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1600000
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.049
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M24D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.049
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1624000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1599000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1171000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	823000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	700000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	626000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6543000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	737000
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	5806000
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1366000
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4440000
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	5806000
CY2023	amrk	Number Of Related Party Lease NumberOfRelatedPartyLease	1
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25418000
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21350000
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13553000
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11932000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12513000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9845000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2200000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1600000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1400000
CY2023Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	119057000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	55137000
CY2023Q2	amrk	Intangible Assets Accumulated Impairment IntangibleAssetsAccumulatedImpairment	1290000
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	62630000
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	114047000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	44792000
CY2022Q2	amrk	Intangible Assets Accumulated Impairment IntangibleAssetsAccumulatedImpairment	1290000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	67965000
CY2023Q2	us-gaap	Goodwill Gross GoodwillGross	102307000
CY2023Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	1364000
CY2023Q2	us-gaap	Goodwill Goodwill	100943000
CY2022Q2	us-gaap	Goodwill Gross GoodwillGross	102307000
CY2022Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	1364000
CY2022Q2	us-gaap	Goodwill Goodwill	100943000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10300000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25700000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9300000
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	2700000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	8086000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4945000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	752000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	304000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	47000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	138000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14272000
CY2023Q2	amrk	Number Of Investments NumberOfInvestments	7
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	88535000
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	70828000
CY2023Q2	amrk	Equity Method Investment Carrying Value Exceed Book Value EquityMethodInvestmentCarryingValueExceedBookValue	40600000
CY2023Q2	amrk	Trade Payable To Customers And Consignor Payables Current TradePayableToCustomersAndConsignorPayablesCurrent	20512000
CY2022Q2	amrk	Trade Payable To Customers And Consignor Payables Current TradePayableToCustomersAndConsignorPayablesCurrent	2571000
CY2023Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	4953000
CY2022Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	3556000
CY2023Q2	amrk	Accounts Payable And Other Current Liabilities AccountsPayableAndOtherCurrentLiabilities	25465000
CY2022Q2	amrk	Accounts Payable And Other Current Liabilities AccountsPayableAndOtherCurrentLiabilities	6127000
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7419000
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	17456000
CY2023Q2	amrk	Accounts Payable Advance From Customers Current AccountsPayableAdvanceFromCustomersCurrent	173944000
CY2022Q2	amrk	Accounts Payable Advance From Customers Current AccountsPayableAdvanceFromCustomersCurrent	158089000
CY2023Q2	amrk	Deferred Revenue And Other Advances Current DeferredRevenueAndOtherAdvancesCurrent	181363000
CY2022Q2	amrk	Deferred Revenue And Other Advances Current DeferredRevenueAndOtherAdvancesCurrent	175545000
CY2023	amrk	Derivative Open Position Expected Settlement Period DerivativeOpenPositionExpectedSettlementPeriod	P2D
CY2023Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	93848000
CY2023Q2	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	15967000
CY2023Q2	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0
CY2023Q2	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	77881000
CY2022Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	99141000
CY2022Q2	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	7398000
CY2022Q2	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0
CY2022Q2	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	91743000
CY2023Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	22734000
CY2023Q2	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	1418000
CY2023Q2	us-gaap	Derivative Liability Collateral Right To Reclaim Cash Offset DerivativeLiabilityCollateralRightToReclaimCashOffset	13240000
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	8076000
CY2022Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	100451000
CY2022Q2	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	2373000
CY2022Q2	us-gaap	Derivative Liability Collateral Right To Reclaim Cash Offset DerivativeLiabilityCollateralRightToReclaimCashOffset	22298000
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	75780000
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	97083000
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	47825000
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-125622000
CY2023Q2	amrk	Restricted And Non Restricted Inventory Net RestrictedAndNonRestrictedInventoryNet	981643000
CY2022Q2	amrk	Restricted And Non Restricted Inventory Net RestrictedAndNonRestrictedInventoryNet	741018000
CY2023Q2	amrk	Asset Under Financing Agreement With Repurchase Option AssetUnderFinancingAgreementWithRepurchaseOption	25530000
CY2022Q2	amrk	Asset Under Financing Agreement With Repurchase Option AssetUnderFinancingAgreementWithRepurchaseOption	79766000
CY2023Q2	amrk	Inventoryand Precious Metal Held Under Financing Arrangements InventoryandPreciousMetalHeldUnderFinancingArrangements	1007173000
CY2022Q2	amrk	Inventoryand Precious Metal Held Under Financing Arrangements InventoryandPreciousMetalHeldUnderFinancingArrangements	820784000
CY2023Q2	amrk	Inventory Commemorative Coin Stated At Lower Cost Or Market InventoryCommemorativeCoinStatedAtLowerCostOrMarket	948000
CY2022Q2	amrk	Inventory Commemorative Coin Stated At Lower Cost Or Market InventoryCommemorativeCoinStatedAtLowerCostOrMarket	1434000
CY2023Q2	amrk	Inventory Purchase Premium On Metals Positionmarkedtomarket InventoryPurchasePremiumOnMetalsPositionmarkedtomarket	29358000
CY2022Q2	amrk	Inventory Purchase Premium On Metals Positionmarkedtomarket InventoryPurchasePremiumOnMetalsPositionmarkedtomarket	27059000
CY2023Q2	amrk	Inventory Purchase Precious Metal Position Value Not Hedged InventoryPurchasePreciousMetalPositionValueNotHedged	30306000
CY2022Q2	amrk	Inventory Purchase Precious Metal Position Value Not Hedged InventoryPurchasePreciousMetalPositionValueNotHedged	28493000
CY2023Q2	amrk	Open Inventory Purchase Commitments OpenInventoryPurchaseCommitments	921108000
CY2022Q2	amrk	Open Inventory Purchase Commitments OpenInventoryPurchaseCommitments	681835000
CY2023Q2	amrk	Open Inventory Sale Commitments OpenInventorySaleCommitments	587392000
CY2022Q2	amrk	Open Inventory Sale Commitments OpenInventorySaleCommitments	497949000
CY2023Q2	amrk	Margin Sale Commitments MarginSaleCommitments	17682000
CY2022Q2	amrk	Margin Sale Commitments MarginSaleCommitments	26984000
CY2023Q2	amrk	Deferred Liability Not Subject To Market Risk DeferredLiabilityNotSubjectToMarketRisk	5505000
CY2022Q2	amrk	Deferred Liability Not Subject To Market Risk DeferredLiabilityNotSubjectToMarketRisk	13164000
CY2023Q2	amrk	Unhedgable Premiums On Open Commitment Positions UnhedgablePremiumsOnOpenCommitmentPositions	11224000
CY2022Q2	amrk	Unhedgable Premiums On Open Commitment Positions UnhedgablePremiumsOnOpenCommitmentPositions	12933000
CY2023Q2	amrk	Inventory Borrowed From Suppliers InventoryBorrowedFromSuppliers	21642000
CY2022Q2	amrk	Inventory Borrowed From Suppliers InventoryBorrowedFromSuppliers	59417000
CY2023Q2	amrk	Obligation Under Product Financing Agreement ObligationUnderProductFinancingAgreement	335831000
CY2022Q2	amrk	Obligation Under Product Financing Agreement ObligationUnderProductFinancingAgreement	282671000
CY2023Q2	amrk	Advances Payments On Industrial Metals AdvancesPaymentsOnIndustrialMetals	698000
CY2022Q2	amrk	Advances Payments On Industrial Metals AdvancesPaymentsOnIndustrialMetals	768000
CY2023Q2	amrk	Commitment At Market CommitmentAtMarket	35022000
CY2022Q2	amrk	Commitment At Market CommitmentAtMarket	184649000
CY2023Q2	amrk	Inventory Subject To Price Risk InventorySubjectToPriceRisk	941845000
CY2022Q2	amrk	Inventory Subject To Price Risk InventorySubjectToPriceRisk	607642000
CY2023Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	938233000
CY2022Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	605039000
CY2023Q2	amrk	Net Inventory Subject To Price Risk NetInventorySubjectToPriceRisk	3612000
CY2022Q2	amrk	Net Inventory Subject To Price Risk NetInventorySubjectToPriceRisk	2603000
CY2023Q2	amrk	Open Inventory Purchase Commitments OpenInventoryPurchaseCommitments	921108000
CY2022Q2	amrk	Open Inventory Purchase Commitments OpenInventoryPurchaseCommitments	681835000
CY2023Q2	amrk	Open Inventory Sale Commitments OpenInventorySaleCommitments	587392000
CY2022Q2	amrk	Open Inventory Sale Commitments OpenInventorySaleCommitments	497949000
CY2023Q2	amrk	Margin Sale Commitments MarginSaleCommitments	17682000
CY2022Q2	amrk	Margin Sale Commitments MarginSaleCommitments	26984000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	203139000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	166379000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	192771000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	31000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	38000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	30000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	203170000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	166417000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	192801000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	39408000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	32518000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	28899000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5371000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4701000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4954000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	37000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	225000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	97000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	44816000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	37444000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	33950000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	178000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3281000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2961000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1407000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-825000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	888000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1585000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4106000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2073000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46401000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33338000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31877000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.228
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.200
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.165
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	42666000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	34947000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	40488000
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5083000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3236000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3935000
CY2021	amrk	Effective Income Tax Rate Reconciliation Adjustment Related To Acquisition EffectiveIncomeTaxRateReconciliationAdjustmentRelatedToAcquisition	-9539000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount	791000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount	1476000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount	2427000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-1171000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-3075000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-1233000
CY2021	amrk	Incometaxreconciliationreversalofpreacquisitiondeferredtaxesinjointventure Incometaxreconciliationreversalofpreacquisitiondeferredtaxesinjointventure	-981000
CY2023	amrk	Incometaxreconciliationstateratechange Incometaxreconciliationstateratechange	202000
CY2022	amrk	Incometaxreconciliationstateratechange Incometaxreconciliationstateratechange	-171000
CY2021	amrk	Incometaxreconciliationstateratechange Incometaxreconciliationstateratechange	950000
CY2023	amrk	Incometaxreconciliationpermanentadjustments Incometaxreconciliationpermanentadjustments	311000
CY2022	amrk	Incometaxreconciliationpermanentadjustments Incometaxreconciliationpermanentadjustments	-252000
CY2021	amrk	Incometaxreconciliationpermanentadjustments Incometaxreconciliationpermanentadjustments	266000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	30000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	217000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	91000
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	71000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-88000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	327000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46401000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33338000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31877000
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1000000.0
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	400000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	195000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	58000
CY2023Q2	amrk	Deferredtaxassetsleaseliabilities Deferredtaxassetsleaseliabilities	1800000
CY2022Q2	amrk	Deferredtaxassetsleaseliabilities Deferredtaxassetsleaseliabilities	1804000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1409000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1222000
CY2023Q2	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	422000
CY2022Q2	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	368000
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2000
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	855000
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	39000
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	34000
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3867000
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4341000
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	13111000
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	15071000
CY2023Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1036000
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1000000
CY2023Q2	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	4534000
CY2022Q2	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	2052000
CY2023Q2	amrk	Deferred Tax Liabilities Investment In Partnership DeferredTaxLiabilitiesInvestmentInPartnership	204000
CY2023Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1637000
CY2022Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1617000
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	22000
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	9000
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	20544000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	19749000
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	16677000
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	15408000
CY2023Q2	amrk	Operating Loss Carryforward Tax Effected OperatingLossCarryforwardTaxEffected	0.0
CY2022Q2	amrk	Operating Loss Carryforward Tax Effected OperatingLossCarryforwardTaxEffected	900000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	146000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	277000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	163000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	93000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	38000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	26000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	140000
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	146000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	146000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	277000
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	146000
CY2023Q2	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	69000
CY2023Q2	us-gaap	Income Tax Examination Penalties Accrued IncomeTaxExaminationPenaltiesAccrued	37000
CY2023Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	252000
CY2023Q2	us-gaap	Due From Related Parties DueFromRelatedParties	1271000
CY2023Q2	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	2977000
CY2022Q2	us-gaap	Due From Related Parties DueFromRelatedParties	3060000
CY2022Q2	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1975000
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	88300000
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	70600000
CY2023	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1366345000
CY2023	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	95111000
CY2022	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	851854000
CY2022	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	99749000
CY2021	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1698073000
CY2021	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	87969000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12600000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6900000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15500000
CY2023	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1000000.0
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1700000
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	300000
CY2023	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	2600000
CY2022	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	2200000
CY2021	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	1100000
CY2023Q2	amrk	Liability On Borrowed Metals LiabilityOnBorrowedMetals	21600000
CY2022Q2	amrk	Liability On Borrowed Metals LiabilityOnBorrowedMetals	59400000
CY2023Q2	amrk	Obligation Under Product Financing Agreement ObligationUnderProductFinancingAgreement	335800000
CY2022Q2	amrk	Obligation Under Product Financing Agreement ObligationUnderProductFinancingAgreement	282700000
CY2023	amrk	Defined Contribution Plan Automatic Default Contribution For Newly Eligible Employees Percent Of Deducted Pre Tax From Employees Pay DefinedContributionPlanAutomaticDefaultContributionForNewlyEligibleEmployeesPercentOfDeductedPreTaxFromEmployeesPay	0.03
CY2023	amrk	Defined Contribution Plan Employees Eligible Period DefinedContributionPlanEmployeesEligiblePeriod	P21Y
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.90
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1000000.0
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	700000
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	400000
CY2021Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	150000000.0
CY2021Q1	amrk	Remaining Securities Available For Issuance RemainingSecuritiesAvailableForIssuance	69500000
CY2022Q3	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2022-08-18
CY2022Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	23400000
CY2022Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4700000
CY2023Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2023-01-04
CY2023Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-01-16
CY2023Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-01-27
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4700000
CY2023Q2	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2023-04-05
CY2023Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4700000
CY2018Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1000000
CY2022Q2	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	two-for-one
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	335735
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	9800000
CY2023Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1000000
CY2023	us-gaap	Stock Repurchase Program Expiration Date StockRepurchaseProgramExpirationDate	2028-06-30
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2032-10-27
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.4796
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.4176
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0376
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0046
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0210
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	800000
CY2022Q3	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	1.00
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	0
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2499626
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.62
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6061000
CY2020Q2	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	2.67
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	392000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	17.75
CY2021	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageGrantDateFairValue	7.35
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	570370
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.65
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7037000
CY2021	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesWeightedAverageGrantDateFairValue	2.75
CY2021	amrk	Stock Option Activity Cancellations Expirations And Forfeitures StockOptionActivityCancellationsExpirationsAndForfeitures	3200
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	9.33
CY2021	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Cancellations Expirations And Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancellationsExpirationsAndForfeituresWeightedAverageGrantDateFairValue	3.49
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2318056
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.01
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	35343000
CY2021Q2	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	3.44
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1385302
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.88
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	22675000
CY2021Q2	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue	2.89
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2318056
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.01
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	35343000
CY2021Q2	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	3.44
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	538596
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.32
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	15874000
CY2022	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesWeightedAverageGrantDateFairValue	3.22
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1779460
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.84
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	43433000
CY2022Q2	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	3.51
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1147972
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.28
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	29811000
CY2022Q2	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue	2.65
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1779460
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.84
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	43433000
CY2022Q2	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	3.51
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	39.69
CY2023	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageGrantDateFairValue	16.56
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	343200
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.68
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8562000
CY2023	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesWeightedAverageGrantDateFairValue	3.57
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1446260
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.11
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	43882000
CY2023Q2	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	3.58
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1175591
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	5.02
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	38505000
CY2023Q2	amrk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue	2.53
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1446260
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M4D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.11
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1175591
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y10M24D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.02
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	631488
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5.06
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.56
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	370819
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	3.13
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	270669
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	8.14
CY2022Q3	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2022-08-18
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3
CY2023	us-gaap	Revenues Revenues	9286561000
CY2022	us-gaap	Revenues Revenues	8159254000
CY2021	us-gaap	Revenues Revenues	7613015000
CY2023	us-gaap	Revenues Revenues	9286561000
CY2022	us-gaap	Revenues Revenues	8159254000
CY2021	us-gaap	Revenues Revenues	7613015000
CY2023	us-gaap	Gross Profit GrossProfit	294669000
CY2022	us-gaap	Gross Profit GrossProfit	261765000
CY2021	us-gaap	Gross Profit GrossProfit	210198000
CY2023	amrk	Gross Profit Percentage GrossProfitPercentage	0.03173
CY2022	amrk	Gross Profit Percentage GrossProfitPercentage	0.03208
CY2021	amrk	Gross Profit Percentage GrossProfitPercentage	0.02761
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	203170000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	166417000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	192801000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	15877000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	12178000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	5028000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4783000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2879000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2113000
CY2023Q2	amrk	Asset Under Financing Agreement With Repurchase Option AssetUnderFinancingAgreementWithRepurchaseOption	25530000
CY2022Q2	amrk	Asset Under Financing Agreement With Repurchase Option AssetUnderFinancingAgreementWithRepurchaseOption	79766000
CY2023Q2	amrk	Restricted And Non Restricted Inventory Net RestrictedAndNonRestrictedInventoryNet	981643000
CY2022Q2	amrk	Restricted And Non Restricted Inventory Net RestrictedAndNonRestrictedInventoryNet	741018000
CY2023Q2	amrk	Restricted And Non Restricted Inventory Net RestrictedAndNonRestrictedInventoryNet	981643000
CY2022Q2	amrk	Restricted And Non Restricted Inventory Net RestrictedAndNonRestrictedInventoryNet	741018000
CY2023Q2	us-gaap	Assets Assets	1545571000
CY2022Q2	us-gaap	Assets Assets	1442659000
CY2023Q2	us-gaap	Assets Assets	1545571000
CY2022Q2	us-gaap	Assets Assets	1442659000
CY2023Q2	us-gaap	Noncurrent Assets NoncurrentAssets	278380000
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	261534000
CY2023Q2	us-gaap	Noncurrent Assets NoncurrentAssets	278380000
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	261534000
CY2023Q2	us-gaap	Goodwill Goodwill	100943000
CY2022Q2	us-gaap	Goodwill Goodwill	100943000
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	62630000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	67965000

Files In Submission

Name	View Source	Status
0000950170-23-047575-index-headers.html	Edgar Link	pending
0000950170-23-047575-index.html	Edgar Link	pending
0000950170-23-047575.txt	Edgar Link	pending
0000950170-23-047575-xbrl.zip	Edgar Link	pending
amrk-20230630.htm	Edgar Link	pending
amrk-20230630.xsd	Edgar Link	pending
amrk-ex21.htm	Edgar Link	pending
amrk-ex23_1.htm	Edgar Link	pending
amrk-ex31_1.htm	Edgar Link	pending
amrk-ex31_2.htm	Edgar Link	pending
amrk-ex32_1.htm	Edgar Link	pending
amrk-ex32_2.htm	Edgar Link	pending
amrk-ex4_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img204981706_0.jpg	Edgar Link	pending
img204981706_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
amrk-20230630_cal.xml	Edgar Link	unprocessable
amrk-20230630_def.xml	Edgar Link	unprocessable
amrk-20230630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
amrk-20230630_pre.xml	Edgar Link	unprocessable
amrk-20230630_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMRK
A-Mark Precious Metals, Inc. Stock $amrk

2023 Q3 Form 10-K Financial Statement

#000095017023047575 Filed on September 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMRK A-Mark Precious Metals, Inc. Stock $amrk

2023 Q3 Form 10-K Financial Statement

#000095017023047575 Filed on September 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMRK
A-Mark Precious Metals, Inc. Stock $amrk